Back to School: Clarity Clinic Psychiatrist Speaks Out On the Child & Adolescent Mental Health Crisis
24 août 2022 12h30 HE | Clarity Clinic
CHICAGO, Aug. 24, 2022 (GLOBE NEWSWIRE) -- As the summer months come to a close, many young students prepare to head back to school. Although this time can be filled with excitement, the crisis in...
COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa
28 juil. 2022 04h00 HE | COMPASS Pathways
Multi-centre, double-blind randomised controlled phase II trial will investigate the efficacy of COMP360 psilocybin therapy in anorexia nervosa for which there is currently no approved pharmacological...
Clarity Clinic to Sponsor Chicago Market Days Festival
21 juil. 2022 14h00 HE | Clarity Clinic
CHICAGO, July 21, 2022 (GLOBE NEWSWIRE) -- Clarity Clinic is proudly sponsoring the 40th Northalsted Market Days®, a weekend-long live music street festival celebrating community in Chicago's...
compass_positive_tagline-01.png
COMPASS Pathways appoints Kabir Nath as Chief Executive Officer
19 juil. 2022 08h00 HE | COMPASS Pathways
Kabir Nath will build upon COMPASS’ success and lead the development of novel models of care to accelerate patient access to evidence-based innovation in mental health care George Goldsmith remains...
Grow Therapy Logo.png
Grow Therapy Joins Evernorth’s Behavioral Health Network to Increase Access to High-Quality Mental Health Care
08 juin 2022 09h05 HE | Grow Therapy
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Grow Therapy, a leader in helping create life-changing therapeutic connections between therapists and clients, today announced its mental health care...
Clarity Clinic Opens Doors to Evanston Clinic
06 juin 2022 17h31 HE | Clarity Clinic
EVANSTON, Ill., June 06, 2022 (GLOBE NEWSWIRE) -- Clarity Clinic's Evanston clinic has officially opened its doors. The new 5,600 square-foot clinic in Evanston is the fifth Clarity Clinic location...
COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting
23 mai 2022 07h00 HE | COMPASS Pathways
Positive data from phase IIb study shows potential of COMP360 psilocybin therapy in treatment-resistant depression London, UK – 23 May 2022        COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a...
COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults
09 mai 2022 07h00 HE | COMPASS Pathways
London, UK – 9 May 2022 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today...
compass_positive_tagline-01.png
COMP360 psilocybin therapy shows potential in exploratory open-label studies for anorexia nervosa and severe treatment-resistant depression
03 mai 2022 07h00 HE | COMPASS Pathways
Positive early signals seen in two investigator-initiated studies presented at the Society of Biological Psychiatry Annual Meeting in New Orleans London, UK – 3 May 2022        COMPASS...
compass_positive_tagline-01.png
COMPASS Pathways partners with One Mind to fund Rising Star Awards for the next generation of mental health researchers
20 avr. 2022 07h00 HE | COMPASS Pathways
London, UK – 20 April 2022     COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...